SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Farallon Capital Management LLC/Adv, et al. – ‘SC 13D/A’ on 8/5/99 re: Allergan Specialty Therapeutics Inc

On:  Thursday, 8/5/99   ·   Accession #:  1012168-99-59   ·   File #:  5-53925

Previous ‘SC 13D’:  ‘SC 13D’ on 7/29/99   ·   Latest ‘SC 13D’:  This Filing

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer

 8/05/99  Farallon Capital Mgmt LLC/Adv     SC 13D/A               1:69K  Allergan Specialty Therapeut… Inc
          Andrew B. Fremder
          David I. Cohen
          Enrique Boilini
          Farallon Capital (CP) Investors, L.P.
          Farallon Capital Institutional Partners II, L.P.
          Farallon Capital Institutional Partners III, L.P.
          Farallon Capital Institutional Partners, L.P.
          Farallon Capital Management LLC/Adv
          Farallon Capital Partners, L.P.
          Farallon Partners, L.L.C.
          Fleur E. Fairman
          Jason M. Fish
          Joseph F. Downes
          Meridee A. Moore
          Richard B. Fried
          Stephen L. Millham
          Thomas F. Steyer
          Tinicum Partners, L.P.
          William F. Duhamel
          William F. Mellin

Amendment to General Statement of Beneficial Ownership   —   Schedule 13D
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: SC 13D/A    Amendment No. 13                                      36    126K 




        
Filing Submission 0001012168-99-000059 – SGML Text

Original SGML Text submitted by:  Farallon Capital Management LLC/Adv

To view the SGML, please refresh
Refresh emoji
this page.


Top

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Wed., May 15, 1:18:21.2am ET